TBPH
NASDAQ · Pharmaceuticals
Theravance Biopharma Inc
$16.79
+0.05 (+0.30%)
Open$16.72
Previous Close$16.74
Day High$16.86
Day Low$16.57
52W High$21.03
52W Low$8.33
Volume—
Avg Volume289.3K
Market Cap859.16M
P/E Ratio8.11
EPS$2.03
SectorPharmaceuticals
Analyst Ratings
Buy
12 analysts
Price Target
+48.6% upside
Current
$16.79
$16.79
Target
$24.95
$24.95
$16.23
$24.95 avg
$30.59
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 106.76M | 83.44M | 591.55M |
| Net Income | 105.20M | 74.00M | 75.68M |
| Profit Margin | 98.5% | 93.6% | 12.8% |
| EBITDA | 47.71M | 35.42M | 125.32M |
| Free Cash Flow | — | — | 94.80M |
| Rev Growth | +28.0% | +28.0% | +8.8% |
| Debt/Equity | 0.11 | 0.11 | 1.02 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |